These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9166990)

  • 1. Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs.
    Schwartz LM; Jennings RB; Reimer KA
    Basic Res Cardiol; 1997 Apr; 92(2):106-14. PubMed ID: 9166990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary administration of the alpha 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs.
    Sebbag L; Katsuragawa M; Verbinski S; Jennings RB; Reimer KA
    Cardiovasc Res; 1996 Nov; 32(5):830-8. PubMed ID: 8944813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.
    Przyklenk K; Bauer B; Ovize M; Kloner RA; Whittaker P
    Circulation; 1993 Mar; 87(3):893-9. PubMed ID: 7680290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
    Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
    Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
    Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
    Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.
    Kersten JR; Schmeling TJ; Pagel PS; Gross GJ; Warltier DC
    Anesthesiology; 1997 Aug; 87(2):361-70. PubMed ID: 9286901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.
    Yao Z; Gross GJ
    Circulation; 1994 Mar; 89(3):1229-36. PubMed ID: 8124811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
    Vander Heide RS; Schwartz LM; Reimer KA
    Cardiovasc Res; 1994 Oct; 28(10):1526-32. PubMed ID: 8001041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of catecholamine depletion on myocardial infarct size in dogs: role of catecholamines in ischemic preconditioning.
    Vander Heide RS; Schwartz LM; Jennings RB; Reimer KA
    Cardiovasc Res; 1995 Nov; 30(5):656-62. PubMed ID: 8595609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
    Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
    Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo.
    Kehl F; Pagel PS; Krolikowski JG; Gu W; Toller W; Warltier DC; Kersten JR
    Anesth Analg; 2002 Nov; 95(5):1162-8, table of contents. PubMed ID: 12401584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preconditioning improves myocardial function and reflow, but not vasodilator reactivity, after ischaemia and reperfusion in anaesthetized dogs.
    Loke KE; Woodman OL
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):552-8. PubMed ID: 9673427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
    Auchampach JA; Grover GJ; Gross GJ
    Cardiovasc Res; 1992 Nov; 26(11):1054-62. PubMed ID: 1291082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protection is lost before contractile function recovers from ischemic preconditioning.
    Murry CE; Richard VJ; Jennings RB; Reimer KA
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H796-804. PubMed ID: 2000974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model?
    Przyklenk K; Sussman MA; Simkhovich BZ; Kloner RA
    Circulation; 1995 Sep; 92(6):1546-57. PubMed ID: 7664439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning with supply-demand imbalance limits infarct size in dog heart.
    Iwamoto T; Bai XJ; Downey HF
    Cardiovasc Res; 1993 Nov; 27(11):2071-6. PubMed ID: 8287420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hyperglycemia abolishes ischemic preconditioning in vivo.
    Kersten JR; Schmeling TJ; Orth KG; Pagel PS; Warltier DC
    Am J Physiol; 1998 Aug; 275(2):H721-5. PubMed ID: 9683464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.